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1  | INTRODUC TION
Offer acceptance practices are receiving increasing attention in the 
transplant community. Transplant typically confers a survival benefit 
to candidates compared with remaining on the waiting list1-5; there-
fore, high offer acceptance may improve survival outcomes for listed 
candidates through better access to transplant. This relationship 
was established in liver transplantation, where low program- specific 
acceptance of the first organ offer was associated with additional 
mortality on the waiting list.6 In addition, offer  acceptance is a con-
ceptual component of allocation efficiency  because below average 
offer acceptance may lead to nonlocal organ placement, longer cold 
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Variation in heart and lung offer acceptance practices may affect numbers of trans-
planted organs and create variability in waitlist mortality. To investigate these issues, 
offer acceptance ratios, or adjusted odds ratios, for heart and lung transplant pro-
grams	 individually	and	for	all	programs	within	donation	service	areas	 (DSAs)	were	
estimated using offers from donors recovered July 1, 2016, and June 30, 2017. 
Logistic	regressions	estimated	the	association	of	DSA-	level	offer	acceptance	ratios	
with	donor	yield	and	local	placement	of	organs	recovered	in	the	DSA.	Competing	risk	
methodology estimated the association of program- level offer acceptance ratios 
with	 incidence	and	rate	of	waitlist	 removals	due	to	death	or	becoming	too	sick	 to	
undergo	transplant.	Higher	DSA-	level	offer	acceptance	was	associated	with	higher	
yield (odds ratios [ORs]: lung, 1.041.111.19; heart, 1.091.211.35)	and	more	 local	place-
ment of transplanted organs (ORs: lung, 1.011.121.24; heart, 1.471.691.93).	 Higher	
program- level offer acceptance was associated with lower incidence of waitlist re-
moval	due	to	death	or	becoming	too	sick	to	undergo	transplant	(hazard	ratios	[HRs]:	
heart, 0.800.860.93; lung, 0.670.750.83),	but	not	with	rate	of	waitlist	removal	(HRs:	heart,	
0.910.981.06; lung, 0.890.991.10).	 Heart	 and	 lung	 offer	 acceptance	 practices	 affected	
numbers of transplanted organs and contributed to program- level variability in the 
probability of waitlist mortality.
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a	donor),	 lower	cold	 ischemia	time,	and	higher	odds	of	 local	organ	
placement.7
Despite potentially important practical implications, organ offer 
data	are	limited	in	complex	ways	that	may	obscure	the	expected	asso-
ciation	between	offer	acceptance	and	waitlist	mortality.	Specifically,	
organ offer data can only evaluate offers for eventually accepted 
organs, and programs can screen offers out of match runs (ie, never 
receive	an	offer)	from	donors	with	certain	clinical	characteristics;	for	
example,	lung	programs	may	not	transplant	lungs	from	donors	who	
recently	 smoked.	 Programs	 that	 aggressively	 screen	 offers	 could	
achieve good apparent offer acceptance despite providing poor ac-
cess to transplant. Conversely, programs that consider every offer 
may have low apparent offer acceptance but provide better access 
to	transplant.	This	may	attenuate	the	expected	association	of	offer	
acceptance with waitlist mortality because offer acceptance may no 
longer reflect program- level variability in access to transplant. Thus, 
due to the difficult and potentially confounding nature of offer ac-
ceptance data, an empirical evaluation is necessary to establish the 
association between offer acceptance and waitlist mortality.
In heart and lung transplantation, organ offer acceptance prac-
tices are particularly important due to relatively high rates of waitlist 
mortality8,9	and	low	rates	of	organ	yield	compared	with	kidney	and	
liver transplantation.10	 Thoracic	 transplantation	 differs	 from	 kid-
ney transplantation in important ways that may modify the previ-
ously established association of organ offer acceptance with organ 
yield and local placement of transplanted organs.7 First, hearts and 
lungs	are	more	difficult	 to	 transport	 than	kidneys.	This	 could	 cre-
ate a stronger dependence between the acceptance practices of 
programs	 in	 proximity	 to	 the	donor	 and	organ	 yield.	Because	 low	
acceptance at nearby programs may be more difficult to overcome, 
the offer acceptance practices of nearby heart and lung programs 




and/or recovering hearts or lungs that would be unacceptable to 
local programs.11	Because	offer	acceptance	data	can	only	evaluate	
eventually accepted organs,7 this could attenuate the association 
of heart and lung offer acceptance with organ yield and, especially, 
local	placement	of	transplanted	organs	compared	with	kidney	offer	
acceptance. To determine whether these limitations modify the 
expected	relationships,	we	estimated	the	empirical	associations	of	
offer acceptance with waitlist mortality, organ yield, and local place-




candidates,	and	 transplant	 recipients	 in	 the	United	States,	 submit-
ted by the members of the Organ Procurement and Transplantation 
Network	(OPTN),	and	has	been	described	elsewhere.12	The	Health	
Resources	 and	Services	Administration,	US	Department	of	Health	
and	 Human	 Services,	 provides	 oversight	 of	 the	 activities	 of	 the	
OPTN	and	SRTR	contractors.
2.1 | Heart and lung offer acceptance models
The heart and lung offer acceptance models were estimated with 
offer	data	 (called	match	 runs	 for	 individual	donors)	 for	donors	 re-
covered between July 1, 2016, and June 30, 2017. Discrete- time 
survival models estimated the probability of acceptance separately 
for offers to pediatric and adult candidates from match runs that 




acceptance for each offer. The heart offer acceptance model strati-
fied	offers	to	adult	candidates	by	donor	age:	≤40	or	>40	years.	The	
lung offer acceptance model stratified offers to adult candidates by 
donor	risk	 level:	high-	risk	donors	were	aged	≥55	years,	continually	
used cigarettes in the past 6 months, or donated after circulatory 
death.	Both	models	adjusted	for	several	other	donor/candidate	fac-
tors, including PO2 for lung offer acceptance and ejection fraction 
for heart offer acceptance. Further documentation, including the 
donor/candidate	 factors	 and	 inclusion/exclusion	 criteria,	 are	 ac-
cessible	on	 the	SRTR	website	 (https://www.srtr.org/reports-tools/
risk-adjustment-models-offer-acceptance/).
2.2 | Estimation of program- and DSA- level offer 
acceptance ratios
Heart	 and	 lung	offer	 acceptance	 ratios	were	estimated	 separately	
from the offer acceptance models to alleviate the computational 
burden.	After	the	heart	and	lung	offer	acceptance	models	were	es-
timated,	separate	generalized	linear	mixed	models	(GLMMs)	with	a	
logit	 link	 estimated	 the	 program-	 and	DSA-	level	 offer	 acceptance	
ratios with a corresponding random intercept term.13	The	GLMMs	
accounted for donor and candidate characteristics through an off-
set term equal to the linear predictors from the appropriate offer 
acceptance	model.	These	program-	and	DSA-	level	offer	acceptance	
ratios were used as predictors in the primary analyses.
2.3 | Association of DSA- level offer acceptance 
ratios with organ yield and local placement
Multiple	logistic	regressions	estimated	the	association	between	DSA-	
level	offer	acceptance	ratios	(on	log	base	2	scale)	and	the	likelihood	of	
organ yield and local placement of transplanted organs from donors 
recovered	 in	the	DSA.	The	organ	yield	analysis	used	recovered	do-
nors, that is, donors from whom any solid organ was recovered for the 
purpose of transplant. Donors were included only if the recovering 
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2.4 | Association of program- level offer acceptance 
ratios with waitlist removal due to death or becoming 
too sick to undergo transplant
Waitlist	 mortality	 was	 assessed	 in	 the	 competing	 risk	 framework	
for	 time	 to	 removal	 from	 the	waiting	 list.	 The	 competing	 risks	 of	
waitlist	removal	were	categorized	as	the	following:	removal	due	to	
transplant,	death,	becoming	too	sick	to	undergo	transplant,	or	other	
reasons.	We	were	 interested	 in	 the	 effect	 of	 offer	 acceptance	on	
removal	due	 to	death	or	becoming	 too	 sick	 to	undergo	 transplant	
(ie,	a	composite	outcome).	The	analyses	used	a	period	prevalent	co-
hort of candidates on the waiting list between July 1, 2016, and June 
30, 2017. The time scale was calendar time. Candidates listed after 
July 1, 2016, were left- truncated at the time of listing, and candi-
dates still on the waiting list on June 30, 2017, were right- censored. 
Candidates listed for a heart- or lung- alone transplant were included 
in the analyses.
The association between program- level offer acceptance (on the 
log	base	2	scale)	and	 the	 incidence	of	death	or	becoming	 too	sick	
to	undergo	transplant	was	estimated	with	Fine	and	Gray	methodol-
ogy14 adapted to left- truncation.15 The association of program- level 
offer	acceptance	 (on	the	 log	base	2	scale)	with	the	rate	of	waitlist	
removal	due	 to	death	or	becoming	 too	 sick	 to	undergo	 transplant	
was	estimated	with	a	Cox	proportional	hazards	model	that	censored	
for removal from the list for reasons other than death or becoming 
too	 sick.16,17	 The	 Supplementary	 Materials	 specify	 the	 candidate	
characteristics	included	in	each	model.	Missing	data	were	imputed	
with the median of the non- missing values, and a missing indicator 
was	included	in	the	regression	models.	The	effect	of	continuous	risk	
factors	was	estimated	with	penalized	splines.
The incidence but not the rate of waitlist mortality depends on 
the rate of transplant.16,17	Because	high	offer	acceptance	should	af-
fect waitlist mortality through better access to transplant, we antic-
ipated that high offer acceptance would be associated with lower 
incidence of waitlist mortality but have no association with the rate 
of waitlist mortality. To better evaluate this hypothesis, we esti-
mated the association of offer acceptance with incidence and rate of 
deceased donor transplant.
For both heart and lung transplantation, sensitivity analyses 
considered the effect of program- level offer acceptance ratios on 









3.1 | Characteristics of heart and lung offers 
(Table 1)
For both heart and lung transplantation, the acceptance rate was high-
est	 for	 the	 first	offer	 (28%	and	24%,	 respectively)	and	substantially	
lower	for	organs	with	>10	previous	offers	(3%).	Later	offers	involved,	
on average, older candidates and older recipients. In lung transplan-
tation, later offers involved lower donor PO2 levels and higher pro-
portions	of	donors	with	a	smoking	history.	In	contrast,	donor	ejection	
fraction for heart offers was relatively constant early and late in the 
match run.
TABLE  1 Summary	statistics	for	offered	hearts	and	lungs	across	
different points in the match run
Offer characteristics
Offer 1 Offers 2- 10 Offers >10
Heart	transplantation
Number	of	offers 2941 10,693 24,864
Acceptance 820	(28%) 1514	(14%) 667	(3%)
Candidate characteristics
Age,	yrs. 44	(20) 48	(18) 53	(13)
Status	1 2399	(82%) 6320	(59%) 8842	(36%)
Listed	with	VAD 1085	(37%) 4191	(39%) 11427	(46%)
Donor characteristics





Number	of	offers 2172 9851 23486
Acceptance 520	(24%) 1092	(11%) 714	(3%)
Candidate characteristics
Age,	yrs. 51	(16) 54	(14) 56	(13)
Disease	group	Aa 221	(10%) 2161	(22%) 8438	(36%)
Disease	group	Ba 125	(6%) 563	(6%) 1087	(5%)
Disease group Ca 369	(17%) 1331	(14%) 2578	(11%)
Disease group Da 1457	(67%) 5796	(59%) 11383	(48%)
Donor characteristics
Age,	yrs. 35	(14) 36	(14) 38	(14)










ease; C, cystic fibrosis and immunodeficiency disorders; D, restrictive 
lung disease.
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3.3 | Association of heart and lung offer acceptance 
with organ yield and local placement (Figure 1)
For	both	heart	and	lung	transplantation,	DSA-	level	offer	acceptance	
was associated with organ yield and local placement of donors re-
covered	 in	 the	DSA.	Higher	offer	 acceptance	was	associated	with	
higher odds of organ yield (odds ratios [ORs]: heart, 1.091.211.35; 
lung, 1.041.111.19)	 and	 local	 placement	 of	 organs	 recovered	 in	 the	
DSA	(OR:	heart,	1.471.691.93; lung, 1.011.121.24).	For	example,	doubling	
the	DSA-	level	offer	acceptance	ratio	was	associated	with	21%	and	
11% higher donor yield of, respectively, hearts and lungs. In addi-
tion, the association of lung offer acceptance with local placement 
of	transplanted	lungs	was	relatively	weak,	especially	in	comparison	
with heart transplantation.
3.4 | Association of program- level heart offer 
acceptance with incidence and rate of transplant and 







ceptance ratios between heart transplant programs was associated 
with	a	14%	lower	hazard	for	incidence	of	waitlist	removal	due	to	death	
or	becoming	too	sick.	Heart	offer	acceptance	had	a	slightly	stronger	
association with incidence of waitlist removal due to becoming too 
sick	 (HR:	0.720.810.90),	and	an	attenuated	association	with	 incidence	
Characteristic at listing Lung candidates Heart candidates
Total candidates 4237 7619
Candidates listed during cohort (after July 
1,	2016)
2837	(67%) 3883	(51%)




Removed due to death or becoming too 
sick
333	(8%) 571	(7%)
Removed due to transplant 2344	(55%) 2855	(37%)
Removed due to other reasons 188	(4%) 593	(8%)
Values are n	(%)	or	mean	(standard	deviation).	Removed	due	to	death	or	becoming	too	sick	was	the	
only comparison that was not statistically significant.
TABLE  2 Summary	statistics	of	
candidates waiting for a heart or lung 
transplant and candidate status at the end 
of	the	cohort	period	(June	30,	2017)
F IGURE  1 The	adjusted	odds	ratios	for	a	doubling	of	the	DSA-	
level offer acceptance ratios for organ yield and local placement 
of	organs	recovered	in	the	local	DSA.	The	organ	yield	analysis	
included recovered donors, and the local placement analysis 
included transplanted organs. The heart and lung analyses adjusted 
for	common	donor	factors:	hepatitis	C,	hepatitis	B,	history	of	
hypertension, diabetes status, insulin dependence, mechanism 
of	death,	Public	Health	Service	increased	infectious	risk,	sex,	
blood type, cause of death, circumstance of death, past or current 
cigarette use, past or current cocaine use, past or current use of 
other drugs, current alcohol use, history of cancer, cardiac arrest 
after brain death, history of myocardial infarction, protein in urine, 
recovery	outside	of	the	contiguous	United	States,	pO2, pO2/fiO2, 
serum	creatinine,	body	mass	index,	and	age.	The	heart	models	
also adjusted for ejection fraction, and the lung models for time 
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of	waitlist	removal	due	to	death	(HR:	0.850.941.05).	In	contrast,	heart	
offer acceptance was not associated with the rate of waitlist removal 
for	the	composite	endpoint	(HR:	0.910.981.06)	or,	individually,	for	death	
(HR:	0.951.061.19)	or	becoming	too	sick	(HR:	0.820.911.02).
3.5 | Association of program- level lung offer 
acceptance with incidence and rate of transplant and 
waitlist mortality (Figure 3)












Despite the limitations of organ offer data, we found that high heart 
and	lung	offer	acceptance	within	a	DSA	was	associated	with	higher	
organ yield and lower incidence but not rate of waitlist mortality. 
The distinguishing difference between waitlist mortality incidence 
and rate is that the former depends on the transplant rate.16,17 
Because	 high	 offer	 acceptance	 was	 strongly	 associated	 with	 a	
higher	transplant	rate,	programs	with	high	offer	acceptance	 likely	
had lower incidence of waitlist mortality because they performed 
transplants	before	candidates	died	or	became	too	sick	to	undergo	
transplant.	 However,	 offer	 acceptance	 was	 likely	 not	 associated	
with pretransplant care beyond the effect on access to transplant 
due	to	lack	of	an	association	with	the	waitlist	mortality	rate.	Thus,	
reducing variability in heart and lung offer acceptance practices 
may reduce program- level variability in the incidence of waitlist 
mortality.
Measuring	offer	acceptance	among	heart	and	lung	transplant	pro-
grams provides opportunities for improving organ yield and reduc-
ing variability in waitlist mortality. In particular, the association with 
organ yield suggests that improving offer acceptance could increase 
the	number	of	transplants.	SRTR	recently	integrated	heart	and	lung	
offer acceptance into the program- specific reports to help programs 
benchmark	acceptance	practices	 relative	 to	other	programs.	SRTR	
also	provides	offer	acceptance	cumulative	sum	(CUSUM)	charts	that	
allow monitoring of more recent offer acceptance practices and may 
help	programs	identify	periods	with	unexpectedly	low	offer	accep-
tance.18	As	an	alternative	approach,	information	could	be	provided	
during	 the	 offer	 process	 to	 improve	 acceptance,	 for	 example,	 the	
probability of receiving a better offer within a month.19 Further re-




undergo transplant. The distinguishing difference between incidence and rate is that incidence depends on the rate of every removal reason, 
while	rate	is	independent	of	the	other	removal	reasons.	The	analyses	adjusted	for	several	candidate	characteristics	at	listing:	sex,	blood	
type, life support, height, missing height, weight, age at listing, intraaortic balloon pump, drug- treated hypertension, cardiovascular disease, 
peripheral	vascular	disease,	pulmonary	artery	diastolic	pressure,	missing	pulmonary	artery	diastolic	pressure,	current	or	former	smoking,	
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Approaches	to	reducing	variability	in	offer	acceptance	have	po-
tential limitations. The most important is the ability of programs to 
screen offers out of match runs from donors with certain character-
istics,	for	example,	never	receive	offers	from	donors	aged	older	than	
50 years. This limitation could cause policy and/or regulatory inter-
ventions	to	incentivize	programs	to	screen	offers	out	of	match	runs	
without	necessarily	improving	access	to	transplant.	While	screening	
offers out of match runs could improve organ yield by reducing the 
number of offers required to place an organ, offer acceptance pro-
vides an opportunity to begin a discussion of an important determi-
nant in access to transplant. Thus, further research should consider 
interventions that try to improve the overall acceptance rate, which 
may improve organ yield, while simultaneously reducing the variabil-
ity in access to transplant across programs.
Offer acceptance is a pretransplant metric that does not account 
for posttransplant outcomes. This is potentially problematic because 
programs with high offer acceptance may be transplanting organs 
from	high-	risk	donors	that	may	not	confer	significant	survival	bene-
fit.20	Although	transplant	rates	are	not	associated	with	posttransplant	
outcomes,21 a metric that integrates pretransplant and posttrans-
plant	outcomes	may	better	describe	the	overall	patient	experience	at	
a	program.	For	example,	a	recently	proposed	metric	considered	sur-
vival among lung candidates who underwent transplant,22 although 




confer a survival benefit relative to declining and remaining on the 
waiting list for a better offer. There is substantial research on clinical 
support	 tools	 in	kidney	and	 liver	 transplantation,23-27 but a relative 
paucity of such tools in heart and lung transplantation. This is partic-
ularly important because the organ shortage in heart and lung trans-









therefore be associated with a higher incidence of waitlist mortality. 
Unfortunately,	CPRA	data	are	 insufficiently	collected	 in	heart	and	
lung transplantation, although the recent heart policy called for ad-
ditional	data	collection	for	sensitized	candidates.	The	role	of	CPRA	
in offer acceptance and waitlist mortality should be revisited after 
collection of sufficient relevant data.
We	have	shown	that	organ	offer	acceptance	practices	may	serve	
as an important tool for reducing variability in access to heart and 
lung transplant and improving organ yield. Reducing variability in ac-
cess to transplant is especially important due to the corresponding 
increase in the incidence of waitlist mortality that results from low 
offer acceptance.
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